|
No records
|
|
594 |
21933841000 |
Saptawati Bardosono |
Prof. Dr. dr. Saptawati Bardosono, M.Sc. |
Departemen Ilmu Gizi |
Ilmu Gizi (S3) |
Biofilm-Producing Bacteria and Risk Factors (Gender and Duration of Catheterization) Characterized as Catheter-Associated Biofilm Formation |
Gunardi W.D., Karuniawati A., Umbas R., Bardosono S., Lydia A., Soebandrio A., Safari D. |
International Journal of Microbiology |
2 |
Q3 |
|
|
|
608 |
21933841000 |
Saptawati Bardosono |
Prof. Dr. dr. Saptawati Bardosono, M.Sc. |
Departemen Ilmu Gizi |
Ilmu Gizi (S3) |
Tpmt genetic variability and its association with hematotoxicity in indonesian children with acute lymphoblastic leukemia in maintenance therapy |
Rosdiana D.S., Setiabudy R., Andalusia R., Gatot D., Louisa M., Bardosono S., Instiaty I. |
Pharmacogenomics and Personalized Medicine |
|
Q2 |
|
|
|
654 |
21933841000 |
Saptawati Bardosono |
Prof. Dr. dr. Saptawati Bardosono, M.Sc. |
Departemen Ilmu Gizi |
Ilmu Gizi (S3) |
Feasibility of p16 surrogate biomarker as adjunct diagnosis of oral and oropharyngeal malignancy in a resource-constrained country |
Adham M., Aldino N., Zahra S., Rachmadi L., Bardosono S. |
Acta Oto-Laryngologica |
|
Q2 |
|
|
|
498 |
23473513200 |
Kuntjoro Harimurti |
Dr. dr. Kuntjoro Harimurti, Sp.P.D-KGer., M.Sc. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Common symptoms of alzheimer’s dementia that are easily recognizable by families [Sintomas comuns da demência de alzheimer facilmente reconhecíveis pelas famílias] |
Maryam R.S., Sahar J., Hastono S.P., Harimurti K. |
Dementia e Neuropsychologia |
|
Q3 |
|
|
|
564 |
23473513200 |
Kuntjoro Harimurti |
Dr. dr. Kuntjoro Harimurti, Sp.P.D-KGer., M.Sc. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Clinical Evaluation of HIV/AIDS Patients on Antiretroviral Therapy using HIV Symptoms Index: A reliability and Applicability Evaluation using Indonesian Language |
Shidiq K.M., Nelwan E.J., Yunihastuti E., Harimurti K., Pohan H.T. |
Acta medica Indonesiana |
|
Q3 |
|
|
|
570 |
23473513200 |
Kuntjoro Harimurti |
Dr. dr. Kuntjoro Harimurti, Sp.P.D-KGer., M.Sc. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
The Association of β2-Microglobulin and Fibroblast Growth Factor 23 with Major Adverse Cardiac Event in Acute Coronary Syndrome Patients with Chronic Kidney Disease |
Ginanjar E., Alwi I., Lydia A., Immanuel S., Yamin M., Indrajaya T., Harimurti K. |
Acta medica Indonesiana |
|
Q3 |
|
|
|
618 |
23473513200 |
Kuntjoro Harimurti |
Dr. dr. Kuntjoro Harimurti, Sp.P.D-KGer., M.Sc. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Streptococcus pneumoniae carriage and antibiotic susceptibility among Indonesian pilgrims during the Hajj pilgrimage in 2015 |
Harimurti K., Saldi S.R.F., Dewiasty E., Alfarizi T., Dharmayuli M., Khoeri M.M., Paramaiswari W.T., Salsabila K., Tafroji W., Halim C., Jiang Q., Gamil A., Safari D. |
PLoS ONE |
|
Q1 |
|
|
|
564 |
23474782900 |
Herdiman T. Pohan |
Prof. dr. Herdiman T. Pohan, DTM&H., SpPD(K) |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Clinical Evaluation of HIV/AIDS Patients on Antiretroviral Therapy using HIV Symptoms Index: A reliability and Applicability Evaluation using Indonesian Language |
Shidiq K.M., Nelwan E.J., Yunihastuti E., Harimurti K., Pohan H.T. |
Acta medica Indonesiana |
|
Q3 |
|
|
|
469 |
23475122400 |
Ikhwan Rinaldi |
Dr. dr. Ikhwan Rinaldi, Sp.PD(K). |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Leukapheresis does not improve early survival outcome of acute myeloid leukemia with leukostasis patients – A dual-center retrospective cohort study |
Rinaldi I., Sari R.M., Tedhy V.U., Winston K. |
Journal of Blood Medicine |
|
Q3 |
|
|
|
503 |
23475122400 |
Ikhwan Rinaldi |
Dr. dr. Ikhwan Rinaldi, Sp.PD(K). |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Does immune checkpoint inhibitor increase the risks of poor outcomes in COVID-19-infected cancer patients? A systematic review and meta-analysis |
Lazarus G., Budiman R.A., Rinaldi I. |
Cancer Immunology, Immunotherapy |
|
Q1 |
|
|
